Literature DB >> 11751784

Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones.

Lesley McGee1, Colin E Goldsmith, Keith P Klugman.   

Abstract

Twenty-nine fluoroquinolone (FQ)-resistant clinical isolates of Streptococcus pneumoniae from a collection of isolates from the Alexander Project (1992-1997) and a study from Northern Ireland were identified on the basis of ofloxacin MICs > or = 4 mg/L. DNA fingerprint analyses using BOX-fingerprinting and pulsed-field gel electrophoresis revealed serotype 9V and 23F high-level FQ-resistant strains indistinguishable from the pandemic Spain(23F)-1 and Spain(9V)-3 clones, the type strains of which are low-level resistant or susceptible to the fluoroquinolones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751784     DOI: 10.1093/jac/49.1.173

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

Review 1.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005.

Authors:  Kimberly A Nichol; Heather J Adam; James A Karlowsky; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

3.  Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Authors:  Crystal N Johnson; William H Benjamin Jr; Stephen A Moser; Susan K Hollingshead; Xiaotian Zheng; Marilyn J Crain; Moon H Nahm; Ken B Waites
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread.

Authors:  Michael J Stanhope; Stacey L Walsh; Julie A Becker; Michael J Italia; Karen A Ingraham; Michael N Gwynn; Tom Mathie; James A Poupard; Linda A Miller; James R Brown; Heather Amrine-Madsen
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort.

Authors:  C-I Kang; J-H Song; S H Kim; D R Chung; K R Peck; V Thamlikitkul; H Wang; T M So; P-R Hsueh; R M Yasin; C C Carlos; P H Van; J Perera
Journal:  Infection       Date:  2012-07-22       Impact factor: 3.553

6.  Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.

Authors:  Ralf René Reinert; Susanne Reinert; Mark van der Linden; Murat Y Cil; Adnan Al-Lahham; Peter Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.

Authors:  Mathias W R Pletz; Lesley McGee; James Jorgensen; Bernard Beall; Richard R Facklam; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.

Authors:  George G Zhanel; Lorraine Palatnick; Kimberly A Nichol; Tracy Bellyou; Don E Low; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

10.  Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.

Authors:  Adela G de la Campa; Luz Balsalobre; Carmen Ardanuy; Asunción Fenoll; Emilio Pérez-Trallero; Josefina Liñares
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.